Pedro Perez: Has Computer-Assisted Thrombectomy Actually Improved Patient Care, Or Simply Improved the Tools?
Pedro Perez, Vascular Consultant – PERT and VTE Program Builder at Argon Medical Devices, Inc., shared on LinkedIn:
”Today, we’re entering another shift with Computer Assisted Vacuum Thrombectomy (CAVT) and technologies capable of tissue identification – allowing physicians to distinguish between circulating blood and organized thrombus.
Companies are pushing this tech forward, building on the early work pioneered by physicians.
But the bigger question is this:
Has computer-assisted thrombectomy actually improved patient care… or simply improved the tools?
If these technologies truly deliver greater procedural efficiency, reduced blood loss, and more precise clot removal, then we may be witnessing the next meaningful evolution in VTE treatment.
Curious to hear from others in the field – Are we seeing better outcomes, or just better technology?”
Stay updated with Hemostasis Today.
-
Oct 6, 2026, 22:21Zoltan Nagy: With All Eyes on Optogenetics Today, What Can It Do in Megakaryocytes and Platelets?
-
Oct 6, 2026, 22:13Khalid A. Fakhro: Sidra Medicine Hosts RAPID 2026 Advancing Diagnostics and Treatments for Inborn Errors of Immunity
-
Oct 6, 2026, 22:04Denis Oduor: Preparedness for Postpartum Haemorrhage Must Include Preparedness for Blood
-
Oct 6, 2026, 21:57Farhad Moradpour: Health Equity and Public Health – What Drives Anemia Disparities in Ethnic Minority Populations?
-
Oct 6, 2026, 21:47Yahya Tawfik: Rising Iron Deficiency in the US – 10 Million More Adults Affected Since 1999
-
Oct 6, 2026, 16:43Beth Shirley: Xylitol Consumption Increases Platelet Reactivity and Cardiovascular Risk
-
Oct 6, 2026, 16:37Jared Rice: What Sets the Transfusion Threshold in Anemia of Prematurity?
-
Oct 6, 2026, 16:30Thirunavukkarasu Angappan: Immunoglobulin Decides How Much Plasma Gets Collected
-
Oct 6, 2026, 16:18Gemma Davies: New CMML Research Selected for Presentation at the 68th ASH Annual Meeting